From the last 4C " As we commercialise our technologies, the revenue growth trajectory will continue to be lumpy in coming quarters as initial orders from our distribution partners tend to be large and irregular". The aquisition of KCI has impacted the sales of their wound care product in the short term, but has now given them access to more patients. When buying into companies in their infancy this is common as take up of the product ramps up to base sales.
Management have been honest and disclosed this so in the short term I believe this is an opportunity to take an initial position or top up current holdings. They have a good product, plenty of cash and the story is still intact.
Catalyst for price appreciation will be CE approval and 4 new product launches in 2020.
- Forums
- Charts
- Charts NXS
From the last 4C " As we commercialise our technologies, the...
-
- There are more pages in this discussion • 424 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.42M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5084 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 3832 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5084 | 0.265 |
2 | 42938 | 0.260 |
1 | 25000 | 0.250 |
1 | 2500 | 0.245 |
2 | 6376 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 10324 | 2 |
0.285 | 12524 | 1 |
0.295 | 3390 | 1 |
0.300 | 32437 | 1 |
0.305 | 7749 | 1 |
Last trade - 11.24am 31/07/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online